Author: Dendooven, P.G.
Paper Title Page
MO3C2 Establishment of the New Particle Therapy Research Center (PARTREC) at UMCG Groningen 20
 
  • A. Gerbershagen, L. Barazzuol, S. Both, S. Brandenburg, R.P. Coppes, P.G. Dendooven, B.N. Jones, J.M. Schippers, E.R. Van Der Graaf, P. Van Luijk, M.-J. van Goethem
    PARTREC, Groningen, The Netherlands
 
  After 25 years of successful research in the nuclear and radiation physics domain, the KVI-CART research center in Groningen is upgraded and re-established as the PARticle Therapy REsearch Center (PARTREC). Using the superconducting cyclotron AGOR and being embedded within the University Medical Center Groningen, it operates in close collaboration with the Groningen Proton Therapy Center. PARTREC uniquely combines radiation physics, medical physics, biology and radiotherapy research with an R&D program to improve hadron therapy technology and advanced radiation therapy for cancer. A number of further upgrades, scheduled for completion in 2023, will establish a wide range of irradiation modalities, such as pencil beam scanning, shoot-through with high energy protons and SOBP for protons, helium and carbon ions. Delivery of spatial fractionation (GRID) and dose rates over 300 Gy/s (FLASH) are envisioned. In addition, PARTREC delivers a variety of ion beams and infrastructure for radiation hardness experiments conducted by scientific and commercial communities, and nuclear science research in collaboration with the Faculty of Science and Engineering of the University of Groningen.  
slides icon Slides MO3C2 [12.702 MB]  
DOI • reference for this paper ※ https://doi.org/10.18429/JACoW-HIAT2022-MO3C2  
About • Received ※ 16 June 2022 — Revised ※ 28 June 2022 — Accepted ※ 01 July 2022 — Issue date ※ 10 August 2022
Cite • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)